Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
CN Stock MarketDetailed Quotes
000950 C.Q. Pharmaceutical Holding
- 6.10
- +0.29+4.99%
Market Closed Dec 11 15:00 CST
10.54BMarket Cap24.50P/E (TTM)
6.12High5.80Low513.82KlotVolume5.80Open5.81Pre Close308.86MTurnover2.97%Turnover Ratio16.09P/E (Static)1.73BShares6.2952wk High0.93P/B10.54BFloat Cap4.2052wk Low6.39Limit Up1.73BShs Float14.71Historical High5.23Limit Down5.51%Amplitude0.00Historical Low0.08Dividend TTM6.01Avg Price167.02KlotAsk1.31%Div YieldTTM100Lot Size342.98KlotBid
C.Q. Pharmaceutical Holding Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 2.24%59.69B | -2.30%39.78B | 0.02%19.62B | 18.12%80.12B | 15.54%58.38B | 24.61%40.72B | 23.56%19.62B | 8.49%67.83B | 9.33%50.53B | 8.51%32.67B |
| Operating revenue | 2.24%59.69B | -2.30%39.78B | 0.02%19.62B | 18.12%80.12B | 15.54%58.38B | 24.61%40.72B | 23.56%19.62B | 8.49%67.83B | 9.33%50.53B | 8.51%32.67B |
| Other operating revenue | ---- | 9.50%146.8M | ---- | 55.27%266.8M | ---- | 94.37%134.07M | ---- | 2.97%171.83M | ---- | -10.39%68.98M |
| Total operating cost | 2.77%59.06B | -1.60%39.27B | 0.54%19.38B | 18.65%79.03B | 15.85%57.47B | 24.67%39.91B | 23.22%19.28B | 8.93%66.61B | 9.82%49.6B | 8.79%32.01B |
| Operating cost | 3.04%55.25B | -1.64%36.69B | 0.60%18.1B | 19.03%73.81B | 15.69%53.62B | 24.71%37.3B | 23.34%18B | 9.20%62.01B | 10.16%46.35B | 8.99%29.91B |
| Operating tax surcharges | -4.20%141.88M | -0.65%100.81M | -1.81%42.94M | 16.03%218.86M | 13.63%148.1M | 16.13%101.47M | 19.97%43.73M | 18.30%188.63M | 12.57%130.34M | 20.05%87.38M |
| Operating expense | 3.72%1.71B | -3.40%1.13B | 1.94%556.94M | 8.83%2.21B | 13.33%1.65B | 25.62%1.17B | 16.69%546.32M | 1.66%2.03B | 4.48%1.45B | 4.60%931.77M |
| Administration expense | 6.91%1.13B | 14.92%799.74M | 16.20%423.2M | 16.16%1.49B | 21.26%1.06B | 24.13%695.89M | 26.16%364.21M | 15.48%1.28B | 16.40%872.82M | 14.57%560.6M |
| Financial expense | -17.39%813.81M | -15.12%545.11M | -21.51%257.83M | 18.99%1.3B | 24.17%985.08M | 22.70%642.17M | 25.37%328.47M | 0.61%1.09B | -4.36%793.34M | -0.52%523.35M |
| -Interest expense (Financial expense) | -15.92%861.13M | -13.62%576.86M | -20.70%272.48M | 19.29%1.34B | 26.23%1.02B | 25.61%667.8M | 29.96%343.63M | 1.61%1.12B | -1.52%811.37M | 2.58%531.65M |
| -Interest Income (Financial expense) | -13.31%-70.25M | -14.99%-47.38M | -8.79%-22.83M | -48.09%-91.73M | -52.43%-62M | -65.86%-41.21M | -203.31%-20.99M | -36.93%-61.94M | -5.82%-40.68M | 12.59%-24.84M |
| Research and development | 145.56%8.58M | 837.19%7.05M | -86.68%199.37K | -88.15%383.33K | 201.26%3.49M | 533.67%752.33K | 1,868.88%1.5M | -67.78%3.24M | -72.08%1.16M | -96.52%118.73K |
| Credit Impairment Loss | 5.56%-353.32M | -12.81%-260.49M | -22.43%-172.57M | -321.53%-440.5M | -2,747.46%-374.13M | 15.15%-230.91M | 17.75%-140.96M | 62.02%-104.5M | 95.85%-13.14M | -21.51%-272.14M |
| Asset Impairment Loss | -113.87%-9.79M | 97.99%-89.71K | 96.92%-98.55K | 30.51%-27.76M | -10.25%-4.58M | -50.82%-4.47M | 4.21%-3.2M | -210.06%-39.94M | -173.18%-4.15M | -158.12%-2.97M |
| Other net revenue | 33.70%-86.15M | -11.52%-64.75M | -2.96%-66.57M | -137.51%-80.43M | -148.73%-129.95M | 4.20%-58.06M | -17.77%-64.66M | 13.79%214.4M | 3,044.08%266.67M | -367.98%-60.61M |
| Fair value change income | 778.46%7.05M | 1,010.11%8.91M | 1,098.81%9.62M | 597.24%16.16M | -94.82%802.26K | -97.65%802.26K | -97.73%802.26K | -98.17%2.32M | -77.37%15.49M | -41.74%34.08M |
| Invest income | 19.37%241.92M | 6.72%163.9M | 24.72%86.72M | 2.79%301.55M | -10.72%202.65M | 5.84%153.58M | -12.25%69.53M | -3.09%293.35M | 3.17%226.98M | 0.93%145.11M |
| -Including: Investment income associates | 21.61%243.7M | 12.23%163.35M | 27.71%86.72M | 1.84%291.45M | -8.24%200.4M | 6.27%145.55M | -5.69%67.9M | 2.43%286.19M | 10.52%218.4M | 3.23%136.96M |
| Asset deal income | -52.66%1.14M | -52.47%1.16M | 6,489.93%1.06M | -92.15%788.76K | -76.54%2.4M | -76.14%2.44M | 1,350.67%16.13K | 185.18%10.05M | 3,131.12%10.23M | 3,491.44%10.21M |
| Other revenue | -37.41%26.85M | 6.66%21.86M | -4.96%8.7M | 30.48%69.32M | 37.22%42.9M | -18.32%20.5M | 74.34%9.15M | 22.59%53.13M | 52.67%31.27M | 161.19%25.09M |
| Operating profit | -30.45%548.07M | -40.78%442.53M | -37.22%173.13M | -29.82%1.01B | -34.08%788.05M | 24.04%747.23M | 55.31%275.8M | -8.07%1.44B | 14.48%1.2B | -10.51%602.43M |
| Add:Non operating Income | -21.50%20.12M | -14.23%13.82M | -74.90%3.09M | -31.07%32.78M | -0.03%25.63M | 100.68%16.11M | 307.10%12.3M | 34.81%47.55M | -25.46%25.63M | -65.04%8.03M |
| Less:Non operating expense | 11.42%21.11M | 34.75%10.25M | 200.54%1.48M | 211.15%31.33M | 140.25%18.94M | 65.82%7.61M | -35.03%494.05K | -36.72%10.07M | 79.73%7.88M | 66.14%4.59M |
| Total profit | -31.16%547.08M | -40.97%446.09M | -39.24%174.74M | -31.51%1.01B | -34.49%794.73M | 24.74%755.74M | 59.93%287.6M | -6.82%1.47B | 12.93%1.21B | -12.62%605.87M |
| Less:Income tax cost | -18.21%140.24M | -18.37%103.39M | -28.42%39.97M | -23.73%236.04M | -20.48%171.45M | 19.65%126.66M | 57.26%55.84M | 6.87%309.5M | 15.06%215.61M | -11.41%105.85M |
| Net profit | -34.73%406.84M | -45.52%342.71M | -41.85%134.76M | -33.58%772.5M | -37.52%623.28M | 25.81%629.08M | 60.58%231.76M | -9.89%1.16B | 12.48%997.53M | -12.87%500.02M |
| Net profit from continuing operation | -34.73%406.84M | -45.52%342.71M | -41.85%134.76M | -33.58%772.5M | -37.52%623.28M | 25.81%629.08M | 60.58%231.76M | -9.89%1.16B | 12.48%997.53M | -12.87%500.02M |
| Less:Minority Profit | 8.47%114.62M | -9.36%104.62M | -51.61%31.8M | -44.22%117.54M | -51.47%105.67M | 16.53%115.42M | 102.59%65.72M | -26.12%210.72M | 6.06%217.74M | -27.24%99.05M |
| Net profit of parent company owners | -43.54%292.23M | -53.65%238.09M | -37.99%102.96M | -31.22%654.96M | -33.62%517.61M | 28.10%513.66M | 48.40%166.04M | -5.29%952.28M | 14.42%779.78M | -8.41%400.97M |
| Earning per share | ||||||||||
| Basic earning per share | -43.33%0.17 | -51.72%0.14 | -40.00%0.06 | -30.91%0.38 | -33.33%0.3 | 26.09%0.29 | 66.67%0.1 | -5.17%0.55 | 15.38%0.45 | -8.00%0.23 |
| Diluted earning per share | -43.33%0.17 | -51.72%0.14 | -40.00%0.06 | -30.91%0.38 | -33.33%0.3 | 26.09%0.29 | 66.67%0.1 | -5.17%0.55 | 15.38%0.45 | -8.00%0.23 |
| Other composite income | -150.96%-269.12K | -217.44%-652.45K | -388.67%-41.48M | 264.38%528.05K | 272.95%555.57K | -265.13%-8.49M | 87.83%-321.24K | 87.83%-321.24K | ||
| Other composite income of parent company owners | -143.06%-227.27K | -199.23%-550.99K | ---- | -364.24%-41.03M | 264.38%527.77K | 272.95%555.27K | ---- | -267.64%-8.84M | 87.83%-321.07K | 87.83%-321.07K |
| Other composite income of minority owners | -15,024.38%-41.85K | -34,489.41%-101.45K | ---- | -228.63%-449.95K | 264.37%280.39 | 272.95%295.01 | ---- | 366.11%349.79K | 88.38%-170.58 | 88.38%-170.58 |
| Total composite income | -34.82%406.57M | -45.67%342.05M | -41.85%134.76M | -36.68%731.02M | -37.44%623.81M | 26.00%629.64M | 60.58%231.76M | -10.90%1.15B | 12.78%997.2M | -12.53%499.7M |
| Total composite income of parent company owners | -43.65%292M | -53.81%237.54M | -37.99%102.96M | -34.93%613.93M | -33.53%518.14M | 28.35%514.22M | 48.40%166.04M | -6.66%943.44M | 14.81%779.46M | -7.93%400.65M |
| Total composite income of minority owners | 8.43%114.58M | -9.45%104.52M | -51.61%31.8M | -44.52%117.09M | -51.47%105.67M | 16.53%115.42M | 102.59%65.72M | -25.97%211.07M | 6.07%217.74M | -27.24%99.05M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
